Roderick Y. Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Roderick Y. Kim has a total of 106 co-authors. Here are the top co-authors by number of shared publications:
- Fayette C. Williams
John Peter Smith Hosp Hlth Network, Maxillofacial Oncol & Reconstruct Surg, Ft Worth, TX USA
5 shared publications Fayette C. Williams
Division of Maxillofacial Oncology and Reconstructive Surgery
4 shared publications- Thomas Schlieve
Associate Professor, Graduate Program Director, Division of Oral and Maxillofacial Surgery, Department of Surgery, UT Southwestern Medical Center, Parkland Memorial Hospital, Dallas, TX
4 shared publications Jason N. Burkes
Walter Reed Nation Military Medical Center
3 shared publications- Raymond Patrick Shupak
Oral and Maxillofacial Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
3 shared publications - Timothy W. Neal
Department of Surgery, Division of Oral and Maxillofacial Surgery, UT Southwestern/Parkland Memorial Hospital, Dallas, TX, USA
3 shared publications
Latest Publications
- Open Access
- 23 March 2026
- Published by MDPI AG in Craniomaxillofacial Trauma & Reconstruction
- Vol. 19 (1) , 17
A Prospective, International, Multicentre Registry of Patients Undergoing Segmental Mandibular Defect Reconstruction After Mandibular Resection for Tumours and Drug-Induced Osteonecrosis: A Study Protocol
Segmental mandibular resection may be indicated as a treatment in, for example, advanced stages of oral squamous cell carcinoma (OSCC). Osseous reconstruction of these defects is a fundamental part of static and dynamic masticatory rehabilitation, particularly when dental implants are required. The Segmental Mandibular Defect Reconstruction (SMDR) Registry aims to generate real-world evidence on SMDR through an international, prospective, multicentre case series designed as a registry. While OSCC is a common indication for segmental mandibular resection, the SMDR Registry also aims to capture outcomes for rarer mandibular conditions and the increasing number of collateral damage cases resulting from systemic medication therapies (antiresorptive drugs, immunotherapeutics) or irradiation, which may likewise lead to medication-related osteonecrosis of the mandible (MRONJ) or osteo(radio)necrosis with tumour-like segmental resection of the mandible, highlighting the value of an international database for these less frequent pathologies. Primary objectives are to describe the patient population and current treatment modalities, describe the outcomes and adverse events (AEs) for different treatment modalities, and identify potential predictors for successful autologous reconstruction of SMDs. Approximately 300 patients with a mandibular lesion resulting from bisphosphonate- and immunomodulatory drug-induced osteonecrosis of the mandible, ameloblastoma or osteosarcoma of the mandible, oral metastases related mandibular lesions indicated for segmental resection, or OSCC undergoing SMDR or intending to undergo one- or two-stage reconstruction will be prospectively recruited over a 36-month period. Baseline information, treatment details, and outcome measures will be documented. All treatments will be per the usual practice at participating sites. Outcome measures include clinical, patient-reported, and radiological outcomes; AEs related to the condition and/or treatment with a possible influence on the outcome will be recorded.
- 23 March 2026
- Published by MDPI AG in Craniomaxillofacial Trauma & Reconstruction
- Vol. 19 (1) , 17
Open AccessA Prospective, International, Multicentre Registry of Patients Undergoing Segmental Mandibular Defect Reconstruction After Mandibular Resection for Tumours and Drug-Induced Osteonecrosis: A Study Protocol
Segmental mandibular resection may be indicated as a treatment in, for example, advanced stages of oral squamous cell carcinoma (OSCC). Osseous reconstruction of these defects is a fundamental part of static and dynamic masticatory rehabilitation, particularly when dental implants are required. The Segmental Mandibular Defect Reconstruction (SMDR) Registry aims to generate real-world evidence on SMDR through an international, prospective, multicentre case series designed as a registry. While OSCC is a common indication for segmental mandibular resection, the SMDR Registry also aims to capture outcomes for rarer mandibular conditions and the increasing number of collateral damage cases resulting from systemic medication therapies (antiresorptive drugs, immunotherapeutics) or irradiation, which may likewise lead to medication-related osteonecrosis of the mandible (MRONJ) or osteo(radio)necrosis with tumour-like segmental resection of the mandible, highlighting the value of an international database for these less frequent pathologies. Primary objectives are to describe the patient population and current treatment modalities, describe the outcomes and adverse events (AEs) for different treatment modalities, and identify potential predictors for successful autologous reconstruction of SMDs. Approximately 300 patients with a mandibular lesion resulting from bisphosphonate- and immunomodulatory drug-induced osteonecrosis of the mandible, ameloblastoma or osteosarcoma of the mandible, oral metastases related mandibular lesions indicated for segmental resection, or OSCC undergoing SMDR or intending to undergo one- or two-stage reconstruction will be prospectively recruited over a 36-month period. Baseline information, treatment details, and outcome measures will be documented. All treatments will be per the usual practice at participating sites. Outcome measures include clinical, patient-reported, and radiological outcomes; AEs related to the condition and/or treatment with a possible influence on the outcome will be recorded.
- 1 August 2025
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 83 (8) , 922-924
Leveraging Patient-Reported Outcomes to Facilitate Dental Implant Rehabilitation in Maxillofacial Free Flap Reconstruction
- 1 August 2025
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 83 (8) , 922-924
Leveraging Patient-Reported Outcomes to Facilitate Dental Implant Rehabilitation in Maxillofacial Free Flap Reconstruction
- 28 October 2024
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 83 (2) , 231-239
What Happens After the Free Flap? Evaluation of Aesthetic and Functional Elective Revisions
- 28 October 2024
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 83 (2) , 231-239
What Happens After the Free Flap? Evaluation of Aesthetic and Functional Elective Revisions
- 18 September 2024
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 82 (12) , 1620-1626
Immediate Implants in Fibulas: Does the Implant to Fibula Osteotomy Distance Impact Early Implant Failure?
- 18 September 2024
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 82 (12) , 1620-1626
Immediate Implants in Fibulas: Does the Implant to Fibula Osteotomy Distance Impact Early Implant Failure?
- Open Access
- 29 February 2024
- Published by The Korean Association of Oral and Maxillofacial Surgeons in Journal of the Korean Association of Oral and Maxillofacial Surgeons
- Vol. 50 (1) , 56-59
Diagnostic and management challenge of concurrent tongue squamous cell carcinoma with an unknown parapharyngeal mass
Raymond Shupak, Roderick Kim, Jun Hyuk Huh. JKAOMS 2024;50:56-9. https://doi.org/10.5125/jkaoms.2024.50.1.56
- 29 February 2024
- Published by The Korean Association of Oral and Maxillofacial Surgeons in Journal of the Korean Association of Oral and Maxillofacial Surgeons
- Vol. 50 (1) , 56-59
Open AccessDiagnostic and management challenge of concurrent tongue squamous cell carcinoma with an unknown parapharyngeal mass
Raymond Shupak, Roderick Kim, Jun Hyuk Huh. JKAOMS 2024;50:56-9. https://doi.org/10.5125/jkaoms.2024.50.1.56
- 4 January 2024
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 82 (4) , 494-500
Immediate Teeth in Fibulas Versus Standard Fibula Free Flap: A Comparison of Donor Surgical Site Infections
- 4 January 2024
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 82 (4) , 494-500
Immediate Teeth in Fibulas Versus Standard Fibula Free Flap: A Comparison of Donor Surgical Site Infections
- 28 July 2023
- Published by Springer Nature
- p. 207-222
Advancing Immediate Dental Rehabilitation in Free Tissue Transfer Utilizing Point-of-Care Digital Workflows and 3D Printing
- 28 July 2023
- Published by Springer Nature
- p. 207-222
Advancing Immediate Dental Rehabilitation in Free Tissue Transfer Utilizing Point-of-Care Digital Workflows and 3D Printing
- 11 July 2023
- Published by Elsevier in Journal of Stomatology Oral and Maxillofacial Surgery
- Vol. 124 (6) , 101560
A rare incidence of mandibular metastasis of papillary thyroid carcinoma: A case report and review of literature
- 11 July 2023
- Published by Elsevier in Journal of Stomatology Oral and Maxillofacial Surgery
- Vol. 124 (6) , 101560
A rare incidence of mandibular metastasis of papillary thyroid carcinoma: A case report and review of literature
- Open Access
- 19 May 2023
- Published by Springer Nature in Head and Neck Pathology
- Vol. 17 (3) , 815-820
Early Stage Melanoma of the Vermillion with Mucosal Melanoma in Situ: A Clinical Conundrum
Background: Melanoma is a predominantly cutaneous malignancy associated with sun exposure. Mucosal melanoma is rare and carries a distinct pathogenesis from cutaneous tumors. The vermillion of the lip is a unique site that divides cutaneous from mucosal tissues. Tumors arising on the dry aspect are classified as cutaneous and those of the wet aspect are mucosal. The distinction is importation in tumor staging as all mucosal melanomas are classified as T3-T4b under the current 8th edition American Joint Committee of Cancer (AJCC) guidelines. Methods: We describe a case of early stage melanoma of the vermillion with associated mucosal melanoma in situ. We discuss nuances of management at this site and the distinctions between cutaneous versus mucosal melanomas with a review of the literature. Results: Our patient was treated surgically with 2-3 cm margins. Residual melanoma in situ was present at the mucosal margin on final pathology which required a second surgery for margin revision. The case was discussed at tumor board with recommendation for no further treatment. Conclusions: The nuances between the vermillion and mucosal lip must be understood for appropriate staging and treatment of melanomas. The paucity of literature on melanomas affecting this site render management decisions challenging. Multidisciplinary discussion is essential for guiding care.
- 19 May 2023
- Published by Springer Nature in Head and Neck Pathology
- Vol. 17 (3) , 815-820
Open AccessEarly Stage Melanoma of the Vermillion with Mucosal Melanoma in Situ: A Clinical Conundrum
Background: Melanoma is a predominantly cutaneous malignancy associated with sun exposure. Mucosal melanoma is rare and carries a distinct pathogenesis from cutaneous tumors. The vermillion of the lip is a unique site that divides cutaneous from mucosal tissues. Tumors arising on the dry aspect are classified as cutaneous and those of the wet aspect are mucosal. The distinction is importation in tumor staging as all mucosal melanomas are classified as T3-T4b under the current 8th edition American Joint Committee of Cancer (AJCC) guidelines. Methods: We describe a case of early stage melanoma of the vermillion with associated mucosal melanoma in situ. We discuss nuances of management at this site and the distinctions between cutaneous versus mucosal melanomas with a review of the literature. Results: Our patient was treated surgically with 2-3 cm margins. Residual melanoma in situ was present at the mucosal margin on final pathology which required a second surgery for margin revision. The case was discussed at tumor board with recommendation for no further treatment. Conclusions: The nuances between the vermillion and mucosal lip must be understood for appropriate staging and treatment of melanomas. The paucity of literature on melanomas affecting this site render management decisions challenging. Multidisciplinary discussion is essential for guiding care.
- 14 December 2022
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 81 (2) , 248-253
Does Bulky Adenopathy in Human Papilloma Virus-Positive Oropharyngeal Squamous Cell Carcinoma Require a Planned Post-Treatment Neck Dissection for Occult Residual Disease?
- 14 December 2022
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 81 (2) , 248-253
Does Bulky Adenopathy in Human Papilloma Virus-Positive Oropharyngeal Squamous Cell Carcinoma Require a Planned Post-Treatment Neck Dissection for Occult Residual Disease?